Latest news for Fresenius SE & Co (OTC:FSNUF) Stock

Fresenius SE is a healthcare holding company based in Germany. The company owns a minority stake in dialysis service provider and equipment manufacturer Fresenius Medical Care. The Kabi segment manufactures intravenous drugs, nutrition products, infusion and transfusion therapies, and related pumps. The Helios segment operates private hospitals primarily in Germany and Spain. Vamed provides a variety of services such as healthcare facility construction and operation management, including post-acute care rehabilitation.

News

Rumors

Movers

DANOY

FSNUF

YHOO

Benzinga&#39;s Weekend M&amp;A Chatter

FRESENIUS SE & CO by Fresenius SE & Co. KGaA

Fresenius SE & Co KGaA

Becton, Dickinson boosts syringe production amid FDA concerns on supplies

European losers of higher financing costs - JPMorgan

AbbVie keeps Humira market share near 100% despite biosimilars: report

CVS favors Humira copycats hurting AbbVie's market share: Evercore

March's Dividend Portfolio Update Sets New All-Time Record - 100 Holdings, 21 Buys

Fresenius: It's Darkest Before The Dawn

U.S. dialysis volumes expected to rebound in 2024 despite GLP-1 impact

My Dividend Stock Portfolio: New April Dividend Record - 101 Holdings With 22 Buys

My Dividend Stock Portfolio: New May Dividend Record - 101 Holdings With 22 Buys

Fresenius Medical Care: I Believe The Company Will 'Pop' In 2024-2026

AAPL

ABBV

AGNC

AKZOF

ALIZF

ALSMY

ALVO

AMGN

AMSSY

APLE

ARCC

ASHTF

AVGO

BABA

BASFY

BAYZF

BLUE

BMWYY

BXSL

CBAUF

CCHBF

CHRS

CLNXF

CSCO

CSWC

DSDVF

ELUXY

ENGGF

ERFSF

ETRN

FLUIF

FMCQF

FSNUY

GAIN

GILD

GLAD

GOOD

GRFS

GSBD

GVDBF

HTGC

IFSUF

INTC

LNXSF

MAIN

MBGAF

MFIC

MFICL

MSFT

NEWT

NEXPF

NONOF

NVDA

NVSEF

OBDC

OCDGF

PDRDF

RADCQ

RDEIF

RITM

SDZNY

SDZXF

SEMHF

SHEL

SNMRF

STAG

STWD

SVTRF

TEVA

UNIT

UUGRY

VLEEF

VONOY

VTRS

WZZAF

Fresenius SE & Co

The following are the M&A deals, rumors and chatter circulating on Wall Street for Friday October 3 through Sunday Ocober 5, 2014:

BD to Acquire CareFusion for $12.2B in Cash, Stock

The Deal: Becton, Dickinson and Company (NYSE: <a class="ticker" href="/stock/bdx#NYSE">BDX</a>) and CareFusion Corporation (NYSE: <a class="ticker" href="/stock/cfn#NYSE">CFN</a>) announced Sunday, a definitive agreement under which BD will acquire CareFusion for $58.00 per share in cash and stock, or a total of $12.2 billion. CareFusion shareholders will receive $49.00 in cash and 0.0777 of a share of BD for each share of CareFusion, for a total of $58.00 per CareFusion share based on BD's closing price as of October 3, 2014.

The deal is expected to close in H1 of calendar year 2015.

CareFusion shares closed Friday at $46.17, a gain of almost 2%.


Hearing Unconfirmed Takeover Chatter in Mead Johnson 

The Rumor: Shares of Mead Johnson Nutrition Company (NYSE: <a class="ticker" href="/stock/mjn#NYSE">MJN</a>) rose Friday, following a report Friday from <href="http://www.ft.com/intl/cms/s/0/7de99128-4b17-11e4-8a0e-00144feab7de.html#axzz3FHGDrfWX">Financial Times</a>, that France's Danone (OTC: <a class="ticker" href="/stock/danoy#OTC">DANOY</a>), maker of Dannon Yogurt, was in talks to sell its medical nutrition unit to Germany's Fresnius (OTC: <a class="ticker" href="/stock/fsnuf#OTC">FSNUF</a>), in deal that could value the business at as much as €3 billion, according to sources.

Mead Johnson is also seen as a potential takeover target in the sector.

Mead Johnson shares gained 2.5% Friday to close at $96.54.


Report Platform Specialty Products in Talks to Acquire Arysta Lifescience 

The Rumor: Platform Specialty Products Corp. (NYSE: <a class="ticker" href="/stock/pah#NYSE">PAH</a>) is in advanced talks to acquire Arysta LifeScience Ltd. for around $3.5 billion, according to <WSJ>. Sources say a deal could be reached in the next few weeks.

Bill Ackman's Pershing Square owns a 24% stake in Platform Specialty Products.

Platform Specialty Products closed Friday at $27.01, a gain of 5.5%.


Yahoo Acquires MessageMe

The Deal: The maker of messaging app MessageMe has been acquired, by Yahoo! Inc. (NASDAQ: <a class="ticker" href="/stock/yhoo#NASDAQ">YHOO</a>), <a href="http://www.messageme.com/">as confirmed on the company web site</a> on Friday. MessageMe says the application will be shutting down as of November 7, 2014. 

According to a report from WSJ on Friday, Yahoo was also planning an investment in Snapchat, according to sources, that would value the disappearing message company at ~$10 billion. Snapchat has 100 million uers and almost no revenue.

Yahoo shares closed Friday at $41.03, a gain of more than 1%.

Benzinga's Weekend M&A Chatter

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Comments

Fresenius SE & Co

News

Latest news for Fresenius SE & Co (OTC:FSNUF) Stock

Sunday, October 05, 2014